Mechanisms underlying TAX-mediated neuroprotection against AD or CAA

Potential mechanisms underlying TAX-mediated neuroprotection against AD or CAA. In AD, TAX conferred neuroprotection via decreasing the level of cPLA2 to reduce the synthesis of PGE2, inhibiting neuroinflammation, suppressing the activation of APOE and ERK1/2 signaling to decrease Aβ production, up-regulating SIRT1 expression to inhibit Aβ-induced JAK-2/STAT3 pathway activation, and then decreasing BACE1 expression to ultimately inhibit Aβ aggregation in neurons. In CAA, TAX promoted the breakdown of Aβ, inhibited Aβ oligomer formation, cleared Aβ from the brain to the circulation, and restored the cerebral blood flow (CBF) and cerebrovascular reactivity (CVR)
Mechanisms underlying TAX-mediated neuroprotection against AD or CAA

Publication

New Perspectives of Taxifolin in Neurodegenerative Diseases (2023) Rong Yang, et al. Curr Neuropharmacol. 2023 Aug 15;21(10). Figure: F3.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates SIRT1 SIRT1 ncbigene_symbol SIRT1 23411
Homo sapiens Primates APP APP ncbigene_symbol APP 351
Homo sapiens Primates TAX TAX ncbigene_synonym CNTN2 6900
Homo sapiens Primates CAA CAA ncbigene_synonym TSHZ1 10194
Homo sapiens Primates APOE APOE ncbigene_symbol APOE 348
Homo sapiens Primates ERK1 ERK1 ncbigene_synonym MAPK3 5595
Homo sapiens Primates ERK1/2 ERK2 ncbigene_synonym MAPK1 5594
Homo sapiens Primates BACE1 BACE1 ncbigene_symbol BACE1 23621

Chemical mentions

Word Match MeSH Name ChEBI
PGE2 PGE2 (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid chebi:15551
APP APP chebi:147408

Disease mentions

Word Match MeSH Name DOID